Science
Mechanism of Action
As a naturally occurring analog of Lysophosphatidic Acid (LPA), Cyclic Lysophosphatidic Acid (cPA) exerts its benefits by stimulating hyaluronan (hyaluronic acid) production and increasing the expression of crucial skin proteins like transglutaminase and aquaporin 3. This multifaceted action significantly enhances the skin's water content, leading to a reduction in pore visibility, improved skin elasticity, and a diminished appearance of wrinkles. Its mechanism in human skin fibroblasts for hyaluronic acid synthesis primarily involves the activation of the LPAR1-Gi/o receptor, which then triggers the PI3K, ERK, and CREB signaling pathways.
Research
Clinical Evidence
Medium confidenceN/A
Transparency
Dusting Analysis
No data is available in the provided research for a dusting analysis of Cyclic Lysophosphatidic Acid.
The Formula
Formulation
Stability
Cyclic Phosphatidic Acid is noted for its stability as an LPA analog, maintaining over 75% integrity for up to 24 hours in tissue culture media. However, its cyclic phosphate ring is susceptible to hydrolysis, which can convert it into Lysophosphatidic Acid (LPA), an analog with potentially opposing biological effects. Metabolically stabilized derivatives, such as carba-CPA, have been developed to mitigate this ring-opening hydrolysis. As a phospholipid, it exhibits some solubility in both aqueous and oil phases, often benefiting from solubilizers like cyclodextrin for optimal dispersion. Dilute solutions may demonstrate absorption to plastic and glass surfaces. Oxidation of unsaturated fatty acid chains is possible, suggesting storage under an inert atmosphere for enhanced stability.
Conflicts
- Conditions that promote the hydrolysis of its cyclic phosphate ring (e.g., extreme pH environments or enzymatic activity), as this can convert cPA to LPA and alter its intended biological function.
- Oxidizing conditions, particularly for formulations containing unsaturated fatty acid components, which can lead to degradation.
- Dilute solutions may be incompatible with certain plastic and glass surfaces due to ingredient absorption, potentially reducing effective concentration.
Safety
Safety Profile
Direct safety assessments by regulatory bodies such as CIR, SCCS, or FDA for Cyclic Lysophosphatidic Acid or Cyclic Phosphatidic Acid were not identified in the available research. Reviews for broader categories like 'Lecithin and Other Phosphoglycerides' exist but do not specifically address this ingredient.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Cyclic Lysophosphatidic Acid is a valuable phospholipid analog that significantly enhances skin hydration, elasticity, and pore refinement through increased hyaluronic acid synthesis, though further independent safety reviews would strengthen its profile.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources